IP Library Granted Patent US 12,458,355
Granted Patent B2
US 12,458,355 · App. 17/766,920 · Granted Nov 4, 2025

Medical device for applying force on biological tissue, or the like

Inventors: Felmont F. Eaves (Atlanta, GA); Gary W. Knight (Lebanon, OH)
Assignee: BRIJ Medical, Inc.
A61B17/08A61B17/083A61B17/085A61B2017/00951A61B2017/0495A61B2017/081
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,458,355
App. No.
17/766,920
Granted
Nov 4, 2025
Kind
B2
Abstract

A medical device for at least partially covering and applying force on tissue includes a body having a spanning structure and struts respectively connected to lateral portions of the spanning structure. Inner ends of the struts extend into an area over which the medial portion of the spanning structure extends. The medical device is reconfigurable between extended and retracted configurations. The inner ends of the struts are closer to one another in the retracted configuration than in the extended configuration. The inner ends of the struts are closer to the medial portion of the spanning structure in the retracted configuration than in the extended configuration. Each strut includes an engagement zone configured to engage and apply force on the tissue, at least while the medical device is in the retracted configuration. A web can be connected to the struts and span between the inner ends of the struts.

Claims (70)

1 . A medical device for at least partially covering and applying force on tissue, the medical device comprising:

at least one spanning structure; and

a plurality of struts connected to the at least one spanning structure,

wherein the medical device is configured to have a plurality of configurations comprising at least one unstable equilibrium configuration between concave-up and concave-down stable equilibrium configurations so that the medical device is:

biased toward the concave-up stable equilibrium configuration at least when in configurations between the at least one unstable equilibrium configuration and the concave-up stable equilibrium configuration, and

biased toward the concave-down stable equilibrium configuration at least when in configurations between the at least one unstable equilibrium configuration and the concave-down stable equilibrium configuration;

wherein the medical device is configured so that inner end portions of first and second struts of the plurality of struts become closer to one another at least in response to the medical device being transitioned from the concave-up stable equilibrium configuration to past the at least one unstable equilibrium configuration and toward the concave-down stable equilibrium configuration;

wherein the inner end portions of the first and second struts comprise zones configured to move respective portions of tissue toward one another in response to the inner end portions of the first and second struts becoming closer to one another;

wherein for each of the first and second struts, the strut comprises opposite upper and lower sides, the upper side is positioned between the at least one spanning structure and the lower side, and the zone is on the lower side; and

wherein for each of the first and second struts, the zone comprises adhesive material that is carried by the lower side of the strut, and the adhesive material carried by the lower side of the strut is configured to be adhered to and move a respective portion of tissue at least in response to the first and second struts becoming closer to one another.

2 . The medical device according to claim 1 , wherein the adhesive material is configured to be adhered to and move with respective portions of tissue toward one another at least in response to the first and second struts becoming closer to one another at least in response to the at least one spanning structure transitioning from the concave-up stable equilibrium configuration to past the at least one unstable equilibrium configuration and toward the concave-down stable equilibrium configuration.

3 . The medical device according to claim 1 , wherein the medical device is configured so that:

in the concave-up stable equilibrium configuration, the at least one spanning structure defines a first concavity comprising curved arcs that extend crosswise to one another, and

in the concave-down stable equilibrium configuration, the at least one spanning structure defines a second concavity comprising curved arcs that extend crosswise to one another.

4 . The medical device according to claim 3 , wherein:

the at least one spanning structure comprises opposite end portions that are spaced apart from one another;

the first and second struts respectively extend inwardly from the opposite end portions; and

the first and second struts are inclined downwardly in the concave-up stable equilibrium configuration.

5 . The medical device according to claim 1 , wherein the medical device is configured so that:

in the concave-up stable equilibrium configuration, the at least one spanning structure defines a first concavity comprising curved arcs that extend crosswise to one another, and

in the concave-down stable equilibrium configuration, the at least one spanning structure defines a second concavity comprising curved arcs that extend crosswise to one another.

6 . The medical device according to claim 1 , wherein:

in the concave-up stable equilibrium configuration, the at least one spanning structure defines a first concavity having a radius of curvature, and

in the concave-down stable equilibrium configuration, the at least one spanning structure defines a second concavity having a radius of curvature that is about the same as the radius of curvature of the first concavity.

7 . The medical device according to claim 1 , wherein:

in the concave-up stable equilibrium configuration, the at least one spanning structure defines a first concavity having a radius of curvature, and

in the concave-down stable equilibrium configuration, the at least one spanning structure defines a second concavity having a radius of curvature that is less than the radius of curvature of the first concavity.

8 . The medical device according to claim 1 , wherein:

the at least one spanning structure comprises opposite end portions that are spaced apart from one another; and

the first and second struts respectively extend inwardly from the opposite end portions.

9 . The medical device according to claim 1 , wherein the first and second struts are inclined downwardly in the concave-up stable equilibrium configuration.

10 . The medical device according to claim 1 , wherein:

the first strut comprises an intermediate portion that meets the inner end portion of the first strut at a non-zero angle, so that the inner end portion of the first strut is angled relative to an outer end portion of the first strut; and

the second strut comprises an intermediate portion that meets the inner end portion of the second strut at a non-zero angle, so that the inner end portion of the second strut is angled relative to an outer end portion of the second strut.

11 . The medical device according to claim 1 , wherein:

the first strut is multistable and has the at least one unstable equilibrium configuration, the concave-up stable equilibrium configuration, and the concave-down stable equilibrium configuration, and

the second strut is multistable and has a plurality of configurations comprising an unstable equilibrium configuration between third and fourth stable equilibrium configurations, so that the second strut is:

biased toward the third stable equilibrium configuration at least when in configurations between the unstable equilibrium configuration of the second strut and the third stable equilibrium configuration, and

biased toward the fourth stable equilibrium configuration at least when in configurations between the unstable equilibrium configuration of the second strut and the fourth stable equilibrium configuration.

12 . The medical device according to claim 1 , further comprising at least one release liner adhered to the adhesive material.

13 . The medical device according to claim 1 , wherein the adhesive material is directly adhered to the lower sides of the first and second struts.

14 . The medical device according to claim 1 , further comprising a flexible web connected to the first and second struts, wherein for each of the first and second struts, the flexible web is positioned between the lower side of the strut and the adhesive material, so that the adhesive material is connected to the lower side of the strut by way of at least the flexible web.

15 . A medical device for at least partially covering and applying force on tissue, the medical device comprising:

at least one spanning structure;

first and second struts connected to the at least one spanning structure, wherein for each of the first and second struts, the strut comprises opposite upper and lower sides, and the upper side is positioned between the at least one spanning structure and the lower side;

the medical device being multistable so that:

the medical device has both a concave-up stable equilibrium configuration and a concave-down stable equilibrium configuration,

the medical device has at least one unstable equilibrium configuration between the concave-up and concave-down stable equilibrium configurations,

the medical device is biased toward the concave-up stable equilibrium configuration at least when the medical device is in configurations between the at least one unstable equilibrium configuration and the concave-up stable equilibrium configuration, and

the medical device is biased toward the concave-down stable equilibrium configuration at least when the medical device is in configurations between the at least one unstable equilibrium configuration and the concave-down stable equilibrium configuration;

the medical device being configured so that, in response to the medical device being biased toward the concave-down stable equilibrium configuration, inner end portions the first and second struts automatically become closer to one another in response to the medical device being transitioned from the concave-up stable equilibrium configuration to past the at least one unstable equilibrium configuration and partially toward the concave-down stable equilibrium configuration;

adhesive material connected to the lower sides of the first and second struts so that, for each of the first and second struts, the lower side of the strut is positioned between the upper side of the strut and the adhesive material connected to the strut, wherein the adhesive material is configured to be adhered to and move respective portions of tissue toward one another at least in response to the first and second struts automatically becoming closer to one another in response to the medical device being transitioned from the concave-up stable equilibrium configuration to past the at least one unstable equilibrium configuration and partially toward the concave-down stable equilibrium configuration; and

at least one release liner adhered to the adhesive material.

16 . The medical device according to claim 15 , wherein the adhesive material is directly adhered to the lower sides of the first and second struts.

17 . The medical device according to claim 15 , further comprising a flexible web connected to the first and second struts, wherein for each of the first and second struts, the flexible web is positioned between the lower side of the strut and the adhesive material, so that the adhesive material is connected to the lower side of the strut by way of at least the flexible web.

18 . A medical device for at least partially covering and applying force on tissue, the medical device comprising:

at least one spanning structure;

first and second struts connected to the at least one spanning structure, wherein for each of the first and second struts, the strut comprises opposite upper and lower sides, and the upper side is positioned between the at least one spanning structure and the lower side;

the medical device being multistable so that:

the medical device has both a concave-up stable equilibrium configuration and a concave-down stable equilibrium configuration,

the medical device has at least one unstable equilibrium configuration between the concave-up and concave-down stable equilibrium configurations,

the medical device is biased toward the concave-up stable equilibrium configuration at least when the medical device is in configurations between the at least one unstable equilibrium configuration and the concave-up stable equilibrium configuration, and

the medical device is biased toward the concave-down stable equilibrium configuration at least when the medical device is in configurations between the at least one unstable equilibrium configuration and the concave-down stable equilibrium configuration;

the medical device being configured so that, in response to the medical device being biased toward the concave-down stable equilibrium configuration, inner end portions the first and second struts automatically become closer to one another in response to the medical device being transitioned from the concave-up stable equilibrium configuration to past the at least one unstable equilibrium configuration and partially toward the concave-down stable equilibrium configuration; and

adhesive material connected to the lower side of the first strut, and adhesive material connected to the lower side of the second strut, wherein:

for each of the first and second struts, the lower side of the strut is positioned between the upper side of the strut and the adhesive material connected to the strut, and

the adhesive material connected to the lower side of the first strut, and adhesive material connected to the lower side of the second strut, are cooperatively configured to be adhered to and move respective portions of a workpiece toward one another at least in response to the first and second struts automatically becoming closer to one another in response to the medical device being transitioned from the concave-up stable equilibrium configuration to past the at least one unstable equilibrium configuration and partially toward the concave-down stable equilibrium configuration; and

at least one release liner adhered to the adhesive material.

19 . The medical device according to claim 18 , wherein the adhesive material is directly adhered to the lower sides of the first and second struts.

20 . The medical device according to claim 18 , further comprising a flexible web connected to the first and second struts, wherein for each of the first and second struts, the flexible web is positioned between the lower side of the strut and the adhesive material, so that the adhesive material is connected to the lower side of the strut by way of at least the flexible web.

Assignments (4)
CHANGE OF NAME Recorded Mar 26, 2024
From: BRIJJIT MEDICAL, INC.
To: BRIJ MEDICAL, INC.
Reel/Frame 066895/0527 →
SECURITY INTEREST Recorded Mar 22, 2023
From: BRIJJIT MEDICAL, INC.
To: EMRGE, LLC
Reel/Frame 063144/0165 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2023
From: EMRGE, LLC
To: BRIJJIT MEDICAL, INC.
Reel/Frame 062983/0879 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2022
From: EAVES, FELMONT F.; KNIGHT, GARY W.
To: EMRGE, LLC
Reel/Frame 059519/0134 →
Continuity (2)
Provisional Application 62913754 · Oct 11, 2019
Related Publication 20220346770A1 · Nov 3, 2022
References Cited (255)
US 815264A · Chambers · 1906 [cited by applicant]
US 1248450A · Burke · 1917 [cited by applicant]
US 1908229A · Dyer · 1933 [cited by applicant]
US 2254620A · Miller · 1941 [cited by applicant]
US D134810S · Tawdish · 1943 [cited by applicant]
US 2341121A · Schaaff · 1944 [cited by applicant]
US 2371978A · Perham · 1945 [cited by applicant]
US 2421193A · Gardner · 1947 [cited by applicant]
US 2679671A · Garber, Jr. · 1954 [cited by applicant]
US 2912735A · Johnson et al. · 1959 [cited by applicant]
US 3014483A · McCarthy · 1961 [cited by applicant]
US 3068870A · Levin · 1962 [cited by applicant]
US 3082773A · Renstrom et al. · 1963 [cited by applicant]
US 3120687A · Greening · 1964 [cited by examiner]
US 3254649A · Wood · 1966 [cited by applicant]
US 3487836A · Niebel et al. · 1970 [cited by applicant]
US 3625220A · Engelsher · 1971 [cited by applicant]
US 3695271A · Chodorow · 1972 [cited by applicant]
US 3831608A · Kletschka et al. · 1974 [cited by applicant]
US 3861008A · Wannag · 1975 [cited by applicant]
US 4011639A · Koleske · 1977 [cited by applicant]
US 4275736A · Chodorow · 1981 [cited by applicant]
US D260681S · Chodorow et al. · 1981 [cited by applicant]
US 4506669A · Blake, III · 1985 [cited by applicant]
US 4539990A · Stivala · 1985 [cited by applicant]
US 4646731A · Brower · 1987 [cited by applicant]
US 4702251A · Sheehan · 1987 [cited by applicant]
US D293717S · Proulx et al. · 1988 [cited by applicant]
US 4734320A · Ohira et al. · 1988 [cited by applicant]
US 4742826A · McLorg · 1988 [cited by applicant]
US 4815468A · Annand · 1989 [cited by applicant]
US 4825866A · Pierce · 1989 [cited by applicant]
US 5047047A · Yoon · 1991 [cited by examiner]
US 5127412A · Cosmetto et al. · 1992 [cited by applicant]
US 5176703A · Peterson · 1993 [cited by applicant]
US 5230701A · Meyer et al. · 1993 [cited by applicant]
US 5236440A · Hlavacek · 1993 [cited by applicant]
US 5366480A · Corriveau et al. · 1994 [cited by applicant]
US D354134S · Tanaka · 1995 [cited by applicant]
US D359144S · Healzer et al. · 1995 [cited by applicant]
US 5489083A · Rollor · 1996 [cited by applicant]
US 5549713A · Kim · 1996 [cited by applicant]
US 5562705A · Whiteford · 1996 [cited by applicant]
US 5630430A · Shultz et al. · 1997 [cited by applicant]
US 5775345A · Chou · 1998 [cited by applicant]
US D407489S · Kalat · 1999 [cited by applicant]
US 5947917A · Carte et al. · 1999 [cited by applicant]
US 5947998A · Cartmell et al. · 1999 [cited by applicant]
US 6176868B1 · Detour · 2001 [cited by applicant]
US 6196228B1 · Kreitzer et al. · 2001 [cited by applicant]
US 6559350B1 · Tetreault et al. · 2003 [cited by applicant]
US 6894204B2 · Dunshee · 2005 [cited by applicant]
US D530420S · Chesnin · 2006 [cited by applicant]
US 7332641B2 · Lebner et al. · 2008 [cited by applicant]
US 7683234B2 · Gurtner et al. · 2010 [cited by applicant]
US 7834232B2 · Rastegar et al. · 2010 [cited by applicant]
US 8157839B2 · Riskin et al. · 2012 [cited by applicant]
US 8183428B2 · Gurtner et al. · 2012 [cited by applicant]
US 8246590B2 · Hu et al. · 2012 [cited by applicant]
US D667167S · Stewart · 2012 [cited by applicant]
US D671265S · Stewart · 2012 [cited by applicant]
US 8323313B1 · Belson et al. · 2012 [cited by applicant]
US D674544S · Stewart · 2013 [cited by applicant]
US 8395011B2 · Zepeda et al. · 2013 [cited by applicant]
US 8435221B2 · Hu et al. · 2013 [cited by applicant]
US D683860S · Quimby · 2013 [cited by applicant]
US D690020S · Quimby · 2013 [cited by applicant]
US 8562576B2 · Hu et al. · 2013 [cited by applicant]
US 8592640B2 · Zepeda et al. · 2013 [cited by applicant]
US 8674164B2 · Zepeda et al. · 2014 [cited by applicant]
US 8834434B2 · Hu et al. · 2014 [cited by applicant]
US 8858594B2 · Clark · 2014 [cited by examiner]
US 8915942B2 · Zhang · 2014 [cited by applicant]
US 9028529B2 · Riskin et al. · 2015 [cited by applicant]
US 9050086B2 · Belson et al. · 2015 [cited by applicant]
US 9089328B2 · Belson et al. · 2015 [cited by applicant]
US 9119620B2 · Peterson et al. · 2015 [cited by applicant]
US 9149276B2 · Voss · 2015 [cited by examiner]
US 9241835B2 · Zepeda et al. · 2016 [cited by applicant]
US D754862S · Huff · 2016 [cited by applicant]
US 9301760B2 · Fox · 2016 [cited by applicant]
US 9421133B2 · Hu et al. · 2016 [cited by applicant]
US 9492171B2 · Petenaude · 2016 [cited by applicant]
US 9517163B2 · Goldman et al. · 2016 [cited by applicant]
US D780317S · Vandervoort · 2017 [cited by applicant]
US 9603596B2 · Riskin et al. · 2017 [cited by applicant]
US 9649226B2 · Zepeda et al. · 2017 [cited by applicant]
US D790072S · Hiebert · 2017 [cited by applicant]
US 9668922B2 · Zepeda et al. · 2017 [cited by applicant]
US D811609S · Huff · 2018 [cited by applicant]
US D815747S · Kellock et al. · 2018 [cited by applicant]
US 9974532B2 · Baas et al. · 2018 [cited by applicant]
US 10064616B2 · Lear et al. · 2018 [cited by applicant]
US D831220S · Chase et al. · 2018 [cited by applicant]
US 10092455B2 · Eaves, III · 2018 [cited by applicant]
US 10213350B2 · Jackson et al. · 2019 [cited by applicant]
US D847429S · Sze · 2019 [cited by applicant]
US 10327774B2 · Eaves · 2019 [cited by applicant]
US D854246S · Toba et al. · 2019 [cited by applicant]
US D862695S · Eaves, III et al. · 2019 [cited by applicant]
US D863563S · Herder et al. · 2019 [cited by applicant]
US D863564S · Herder et al. · 2019 [cited by applicant]
US 10426479B2 · Vold et al. · 2019 [cited by applicant]
US 10517768B2 · Zepeda et al. · 2019 [cited by applicant]
US D876641S · Eaves, III et al. · 2020 [cited by applicant]
US D876653S · Heller · 2020 [cited by applicant]
US D887640S · LaFauci · 2020 [cited by applicant]
US 10857037B2 · Jackson et al. · 2020 [cited by applicant]
US 10939912B2 · Leung et al. · 2021 [cited by applicant]
US D918400S · Ma · 2021 [cited by applicant]
US 11051815B2 · Eaves et al. · 2021 [cited by applicant]
US 11051969B2 · Nyberg et al. · 2021 [cited by applicant]
US 11051988B2 · Belson · 2021 [cited by applicant]
US D936846S · Eaves, III et al. · 2021 [cited by applicant]
US D938599S · Kersen et al. · 2021 [cited by applicant]
US 11229555B2 · Eaves, III · 2022 [cited by applicant]
US 11246595B2 · Eaves et al. · 2022 [cited by applicant]
US 11298133B2 · Eaves · 2022 [cited by applicant]
US D956243S · Hood · 2022 [cited by applicant]
US D975291S · Eaves, III et al. · 2023 [cited by applicant]
US D980434S · Eaves, III et al. · 2023 [cited by applicant]
US 11690752B2 · Nyberg et al. · 2023 [cited by applicant]
US 20020111641A1 · Peterson et al. · 2002 [cited by applicant]
US 20030221700A1 · La Fauci · 2003 [cited by applicant]
US 20040204724A1 · Kissel et al. · 2004 [cited by applicant]
US 20050080453A1 · Lebner · 2005 [cited by applicant]
US 20050085757A1 · Santanello · 2005 [cited by applicant]
US 20050193527A1 · Gould · 2005 [cited by applicant]
US 20060200198A1 · Riskin et al. · 2006 [cited by applicant]
US 20070032822A1 · Ortiz et al. · 2007 [cited by applicant]
US 20090125052A1 · Pinna et al. · 2009 [cited by applicant]
US 20090151128A1 · Gould · 2009 [cited by applicant]
US 20090240186A1 · Frang · 2009 [cited by applicant]
US 20090259203A1 · Hu et al. · 2009 [cited by applicant]
US 20100051046A1 · Stevenson et al. · 2010 [cited by applicant]
US 20100081983A1 · Zocher · 2010 [cited by applicant]
US 20100228287A1 · Jeekel · 2010 [cited by applicant]
US 20100236566A1 · Stachowski · 2010 [cited by applicant]
US 20100262126A1 · Hu et al. · 2010 [cited by applicant]
US 20110004173A1 · Hu et al. · 2011 [cited by applicant]
US 20110023906A1 · Tu · 2011 [cited by applicant]
US 20110040325A1 · Moehrle · 2011 [cited by applicant]
US 20110054547A1 · Anderson · 2011 [cited by applicant]
US 20110105963A1 · Hu et al. · 2011 [cited by applicant]
US 20110106026A1 · Wu et al. · 2011 [cited by applicant]
US 20110152738A1 · Zepeda et al. · 2011 [cited by applicant]
US 20120035521A1 · Zepeda et al. · 2012 [cited by applicant]
US 20120071899A1 · Kneifel et al. · 2012 [cited by applicant]
US 20120172779A1 · Spinelli et al. · 2012 [cited by applicant]
US 20120221044A1 · Archibald et al. · 2012 [cited by applicant]
US 20120226214A1 · Gurtner et al. · 2012 [cited by applicant]
US 20130042886A1 · Carey Stachowski · 2013 [cited by examiner]
US 20130150899A1 · Sixto, Jr. et al. · 2013 [cited by applicant]
US 20130178897A1 · Wu et al. · 2013 [cited by applicant]
US 20130282049A1 · Peterson et al. · 2013 [cited by applicant]
US 20130289586A1 · Mazzucco · 2013 [cited by examiner]
US 20140066943A1 · Sixto, Jr. et al. · 2014 [cited by applicant]
US 20140107597A1 · Hu et al. · 2014 [cited by applicant]
US 20140128819A1 · Eaves · 2014 [cited by applicant]
US 20140227483A1 · Eaves · 2014 [cited by applicant]
US 20140243901A1 · Mebarak et al. · 2014 [cited by applicant]
US 20140336701A1 · McLorg · 2014 [cited by applicant]
US 20140343581A1 · Lee · 2014 [cited by applicant]
US 20150005722A1 · Hu et al. · 2015 [cited by applicant]
US 20150012037A1 · Goldman et al. · 2015 [cited by applicant]
US 20150112311A1 · Hammond et al. · 2015 [cited by applicant]
US 20150305739A1 · Rolandi et al. · 2015 [cited by applicant]
US 20160324693A1 · Hu et al. · 2016 [cited by applicant]
US 20170049630A1 · Goldman et al. · 2017 [cited by applicant]
US 20170071596A1 · Lear et al. · 2017 [cited by applicant]
US 20170333039A1 · Leung · 2017 [cited by applicant]
US 20180125492A1 · Eaves · 2018 [cited by applicant]
US 20180303483A1 · Zhang · 2018 [cited by applicant]
US 20180338757A1 · Lear et al. · 2018 [cited by applicant]
US 20180353335A1 · Walker · 2018 [cited by applicant]
US 20190038474A1 · Eaves · 2019 [cited by applicant]
US 20190133582A1 · Eaves et al. · 2019 [cited by applicant]
US 20190261989A1 · Eaves · 2019 [cited by applicant]
US 20210298741A1 · Eaves · 2021 [cited by applicant]
US 20210307751A1 · Eaves et al. · 2021 [cited by applicant]
US 20220142823A1 · Eaves, III · 2022 [cited by applicant]
US 20220225991A1 · Eaves · 2022 [cited by applicant]
US 20220346770A1 · Eaves et al. · 2022 [cited by applicant]
US 20240156456A1 · Eaves et al. · 2024 [cited by applicant]
AU 2012236205B2 · 2016 [cited by applicant]
AU 2016262734 · 2016 [cited by applicant]
CA 2830918A1 · 2012 [cited by applicant]
CN 1889903A · 2007 [cited by applicant]
CN 101606856 · 2009 [cited by applicant]
CN 101828939B · 2010 [cited by applicant]
CN 201683935U · 2010 [cited by applicant]
CN 103892877A · 2014 [cited by applicant]
CN 104755033A · 2015 [cited by applicant]
CN 105147344A · 2015 [cited by applicant]
CN 205144638U · 2016 [cited by applicant]
CN 103533900A · 2016 [cited by applicant]
CN 107530181A · 2018 [cited by applicant]
CN 109862833A · 2019 [cited by applicant]
EP 2691029A2 · 2014 [cited by applicant]
FR 419096 · 1910 [cited by applicant]
FR 1794710 · 1936 [cited by applicant]
JP 2007075596A · 2007 [cited by applicant]
JP 2011500170A · 2011 [cited by applicant]
JP 2012527915 · 2012 [cited by applicant]
JP 2014516288 · 2014 [cited by applicant]
JP 2019513070 · 2019 [cited by applicant]
KR 1020090066415A · 2009 [cited by applicant]
KR 1020140020993 · 2014 [cited by applicant]
TW M340039U · 2008 [cited by applicant]
WO 0226181A1 · 2002 [cited by applicant]
WO 2006124671A2 · 2006 [cited by applicant]
WO 2009049232A1 · 2009 [cited by applicant]
WO 2011019859A2 · 2011 [cited by applicant]
WO 2013188884A1 · 2012 [cited by applicant]
WO 2012135735 · 2012 [cited by applicant]
WO 2013059600 · 2013 [cited by applicant]
WO 2013059600A1 · 2013 [cited by applicant]
WO 2018075879A1 · 2014 [cited by applicant]
WO 2014070922A1 · 2014 [cited by applicant]
WO 20160107897A1 · 2016 [cited by applicant]
WO 2017079782A1 · 2017 [cited by applicant]
WO 2017151806A1 · 2017 [cited by applicant]
WO 2018075879 · 2018 [cited by applicant]
WO 2021072021A1 · 2021 [cited by applicant]
Search Report in counterpart European Application No. 20874568.7 dated Oct. 10, 2023, pp. 1-10 [US. Patent Publication No. 2019/0133582 previously cited.]. [cited by applicant]
Office Action in commonly owned Canadian Application No. 3,158,872 dated Jul. 13, 2023, pp. 1-8. [cited by applicant]
Extended Search Report in related EP Application 12762897.2, Dated May 27, 2015, 11 pages. [cited by applicant]
Japanese Office Action in related JP Application No. 2014-502866, Dated Dec. 10, 2015, Translation provided, 11 pages. [cited by applicant]
Chinese First Office Action in related CN Application No. 201280017051.4, Dated Jun. 1, 2015, Translation provided, 13 pages. [cited by applicant]
Chinese Second Office Action in related CN Application No. 201280017051.4, Dated Dec. 31, 2015, Translation provided, 8 pages. [cited by applicant]
Australian Patent Examination Report No. 1 in related Australian Patent Application No. 201226205, Dated Aug. 28, 2015, 5 pages. [cited by applicant]
International Search Report and Written Opinion issued in commonly owned PCT/US2012/031638 issued Nov. 29, 2012; 10 pages. [cited by applicant]
Supplementary Partial European Search Report in commonly owned EP Application No. 12762897, dated Dec. 23, 2014, 7 pages. [cited by applicant]
Japanese Notice of Reasons for Rejection in related JP Application No. 2014-502866, Mail Date of Oct. 3, 2016; 9 pages. [cited by applicant]
Southmedic Inc., SutureSafe Instructions for Use, 2 pages [Downloaded Jul. 25, 2017 from http://dynamictissuesystems.com/wp-content/uploads/2015/09/IFU0251_E.pdf]. [cited by applicant]
SutureSafe Inc., Product Brochure SutureSafe Support closed wounds and provide stability; 2 pages [Downloaded Jul. 25, 2017 from http://dynamictissuesystems.com/wp-content/uploads/2015/09/SutureSafe-SS-Ir2.pdf]. [cited by applicant]
Search Report in related PCT Application No. PCT/2018/057569, dated Feb. 2, 2018, pp. 1-6. [cited by applicant]
Written Opinion in related PCT Application No. PCT/2018/057569, dated Apr. 26, 2018, pp. 1-5. [cited by applicant]
International Preliminary Report on Patentability in commonly owned International Application No. PCT/US2017/057569, dated May 2, 2019, pp. 1-6. [cited by applicant]
Amazon, “Elastic Bandage Wrap Compression Tape”, Review by Maria A. Dec. 18, 2017, <URL:https://www.amazon.com/Elastic-Bandage-Wrap-Compression-Tape/dp/B06XQ8BY8?th=1> (Year 2017) 12 pages. [cited by applicant]
Supplementary Partial European Search Report in related EP Application No. 12762897, dated Dec. 23, 2014, 7 pages. [cited by applicant]
Examination Report No. 1 in related Australian Application No. 2016262734, dated Jan. 14, 2019, 3 pages. [cited by applicant]
First Chinese Office Action in related CN Application No. 201611102500.1, dated Aug. 20, 2018, 21 pages (including English Translation). [cited by applicant]
Summons to attend oral proceedings in related European Application No. 12762897.2 dated Mar. 22, 2021, pp. 1-11. [cited by applicant]
Partial Supplementary European Search Report in related European Application No. 17861546.4 dated Apr. 22, 2020, pp. 1-12. [cited by applicant]
Search Report in related European Application No. 17861546.4 dated Jul. 31, 2020, pp. 1-10. [cited by applicant]
Kyle Design, Hair Barrettes Made in France—Extra Large 4″ Blank Metal, No date specified, https://www.kyledesigns.com/hair-barrettes-made-in-france-extra-large-4-blank-metal/ (Year: 0) 4 pages. [cited by applicant]
International Search Report and Written Opinion in counterpart International Application No. PCT/US20/54702 dated Mar. 11, 2021, pp. 1-28. [cited by applicant]
Ruckel, U.S. Pat. No. 765,793 issued Jul. 26, 1904, pp. 1-3. [cited by applicant]
Knott et al., “Curved bistable composite slit tubes with positive Gaussian curvature”, University of Surrey, Guilford, United Kingdom, pp. 1-22. [cited by applicant]
Jiang et al., “Snapping of bistable, prestressed cylindrical shells”, A Letters Journal Exploring, www.ep1journal.org, Jun. 2018, EPL, 122 (2018) 64003, pp. 1-8. [cited by applicant]
Kebadze, et al., “Bistable prestressed shell structures”, International Journal of Solids and Structures, www.elsevier.com/locate/ijsolstr, 41 (2004) pp. 2801-2820. [cited by applicant]
Kim et al., “Flytrap-inspired robot using structurally integrated actuation based on bistability and developable surface”, Bioinspiration & Miomimetics, 9 (2014) 036004, pp. 1-15. [cited by applicant]
Seffen, “Morphing bistable orthotropic elliptical shallow shells”, Proceedings of the Roayl Society, (2007) 463, 67-83, pp. 1-17. [cited by applicant]
Extended Search Report in commonly owned European Application No. 23188161.6 dated Oct. 17, 2023, pp. 1-9 [CN 105147344; US. Patent Publication No. 2014/0128819; U.S. Pat. No. 3,487,836; and US 2014/0336701 previously c… [cited by applicant]